Assyro AI

FDA Orange Book · active-ingredient family

Etoposide phosphate

Etoposide phosphate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
ETOPOPHOS PRESERVATIVE FREERLDCHEPLAPHARMNDA 020457May 17, 1996
ETOPOPHOS PRESERVATIVE FREE×2BRISTOL MYERS SQUIBBNDA 020906Feb 27, 1998

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Etoposide phosphate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.